Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
Author Information
Author(s): Michael Levin
Primary Institution: Brighton and Sussex Medical School, University of Sussex
Hypothesis
Do anti-interferon antibodies play a role in the immunopathogenesis of Autoimmune Polyendocrinopathy Syndrome Type 1?
Conclusion
The study identified high levels of anti-interferon antibodies in all patients with APS-1, suggesting they may serve as a diagnostic marker.
Supporting Evidence
- High titre IgG auto-antibodies against Type 1 interferons were found in 100% of APS-1 patients.
- The anti-interferon antibodies neutralised the biological activity of interferon alpha and omega.
- The presence of these antibodies occurred before other auto-antibodies developed.
Takeaway
Some people with a rare disease have special antibodies that might help doctors figure out if they have that disease early on.
Methodology
The study used ELISA-based assays and functional interferon neutralising assays to analyze patient samples.
Limitations
The study does not address the long-term implications of the presence of anti-interferon antibodies.
Participant Demographics
The study involved cohorts of Finnish and Norwegian APS-1 patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website